via Lockton Benefits Insight & Guidance
Hundreds of new specialty drugs are in the approval pipeline. Because these new drugs come with high price tags, the time to begin predicting their impact on your plan’s costs is now, before they hit the market. What kinds of drugs are we talking about?
Here are two examples:
- A cystic fibrosis drug is anticipated for release later this year, and it comes with a price tag of $300,000 per patient, annually.
- New drugs for treating Fabry disease and Wolman disease could cost more than $400,000 per year, each.
To read the full article CLICK HERE